Soluble suppression of tumorigenicity 2 (sST2), but not galactin‐3, adds to prognostication in patients with systemic AL amyloidosis independent of NT‐proBNP and troponin T

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|6|524-528

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.6, 2015-06, pp. : 524-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nt-proBNP in haemodialysis patients: A preliminary study

By Trape Jaume   Perez Alicia   Naval Isabel   Escudero Juan   Comerma Isabel   Sans Antonia   Franquesa Josefina   Vidal Carmen  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 5, 2008-01 ,pp. : 415-420

Informa Healthcare

Access to resources Recommend Favorite

Predictive Role of BNP and NT-proBNP in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 110, Iss. 3, 2008-10 ,pp. : c178-c184

Karger

Access to resources Recommend Favorite

Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients

By Gruson Damien   Alexopoulou Orsalia   Pasquet Agnès   Cumps Jean   Ketelslegers Jean-Marie   Maiter Dominique  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 5, 2012-09 ,pp. : 387-394

Informa Healthcare

Access to resources Recommend Favorite

COPD and Cardiac Death: Pressure (NT-proBNP), Inflammation (CRP) or Both?

By  

Respiration, Vol. 79, Iss. 5, 2010-01 ,pp. : 353-354

Karger

Access to resources Recommend Favorite

TWEAK and NT‐proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 2, 2015-02 ,pp. : 179-186

John Wiley & Sons Inc

Access to resources Recommend Favorite